These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21699209)

  • 21. Neuronal nitric oxide synthase is upregulated in a subset of primary sensory afferents after nerve injury which are necessary for analgesia from alpha2-adrenoceptor stimulation.
    Ma W; Eisenach JC
    Brain Res; 2007 Jan; 1127(1):52-8. PubMed ID: 17113051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
    Hah JM; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice.
    Tanabe M; Nagatani Y; Saitoh K; Takasu K; Ono H
    Neuropharmacology; 2009 Mar; 56(3):702-8. PubMed ID: 19111753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential roles of neuronal and endothelial nitric oxide synthases during carrageenan-induced inflammatory hyperalgesia.
    Tao F; Tao YX; Zhao C; Doré S; Liaw WJ; Raja SN; Johns RA
    Neuroscience; 2004; 128(2):421-30. PubMed ID: 15350652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors.
    Maddaford S; Renton P; Speed J; Annedi SC; Ramnauth J; Rakhit S; Andrews J; Mladenova G; Majuta L; Porreca F
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5234-8. PubMed ID: 21824773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthases.
    Symons KT; Nguyen PM; Massari ME; Anzola JV; Staszewski LM; Wang L; Yazdani N; Dorow S; Muhammad J; Sablad M; Rozenkrants N; Bonefous C; Payne JE; Rix PJ; Shiau AK; Noble SA; Smith ND; Hassig CA; Zhang Y; Rao TS
    J Pharmacol Exp Ther; 2011 Feb; 336(2):468-78. PubMed ID: 21036913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of novel and selective inhibitors for neuronal nitric oxide synthase (nNOS) via structure-based drug design techniques.
    Boumezber S; Yelekçi K
    J Biomol Struct Dyn; 2023 May; 41(8):3607-3629. PubMed ID: 35322764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia.
    Lee DH; Singh JP; Lodge D
    Neurosci Lett; 2005 Sep; 385(3):179-83. PubMed ID: 15964141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents.
    Florio SK; Loh C; Huang SM; Iwamaye AE; Kitto KF; Fowler KW; Treiberg JA; Hayflick JS; Walker JM; Fairbanks CA; Lai Y
    Br J Pharmacol; 2009 Sep; 158(2):494-506. PubMed ID: 19732061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of 4,5-dihydro-1H-pyrazole derivatives as potential nNOS/iNOS selective inhibitors. Part 2: Influence of diverse substituents in both the phenyl moiety and the acyl group.
    Carrión MD; Chayah M; Entrena A; López A; Gallo MA; Acuña-Castroviejo D; Camacho ME
    Bioorg Med Chem; 2013 Jul; 21(14):4132-42. PubMed ID: 23735830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.
    De Felice M; Ossipov MH; Wang R; Dussor G; Lai J; Meng ID; Chichorro J; Andrews JS; Rakhit S; Maddaford S; Dodick D; Porreca F
    Brain; 2010 Aug; 133(Pt 8):2475-88. PubMed ID: 20627971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics.
    Lee WH; Xu Z; Ashpole NM; Hudmon A; Kulkarni PM; Thakur GA; Lai YY; Hohmann AG
    Neuropharmacology; 2015 Oct; 97():464-75. PubMed ID: 26071110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker.
    Wang HY; Qin Y; Li H; Roman LJ; Martásek P; Poulos TL; Silverman RB
    J Med Chem; 2016 May; 59(10):4913-25. PubMed ID: 27050842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variants of neural nitric oxide synthase in the spinal cord of neuropathic rats and their effects on nuclear factor-kappaB (NF-kappaB) activity in PC12 cells.
    Jin XG; He SQ; Yan XT; Zhang G; Wan L; Wang J; Li Y; Tian X; Tian Y; Luo A
    J Pain; 2009 Jan; 10(1):80-9. PubMed ID: 18976964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of benzo[d]thiazol-2-yl-methyl-4-(substituted)-piperazine-1-carbothioamide as novel neuronal nitric oxide inhibitors and evaluation of their neuroprotecting effect in 6-OHDA-induced unilateral lesioned rat model of Parkinson's disease.
    Agrawal S; Kumari R; Sophronea T; Kumari N; Luthra PM
    Biomed Pharmacother; 2022 Dec; 156():113838. PubMed ID: 36274466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
    Cinelli MA; Li H; Pensa AV; Kang S; Roman LJ; Martásek P; Poulos TL; Silverman RB
    J Med Chem; 2015 Nov; 58(21):8694-712. PubMed ID: 26469213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent and selective double-headed thiophene-2-carboximidamide inhibitors of neuronal nitric oxide synthase for the treatment of melanoma.
    Huang H; Li H; Yang S; Chreifi G; Martásek P; Roman LJ; Meyskens FL; Poulos TL; Silverman RB
    J Med Chem; 2014 Feb; 57(3):686-700. PubMed ID: 24447275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of urea and thiourea kynurenamine derivatives: synthesis, molecular modeling, and biological evaluation as nitric oxide synthase inhibitors.
    Chayah M; Carrión MD; Gallo MA; Jiménez R; Duarte J; Camacho ME
    ChemMedChem; 2015 May; 10(5):874-82. PubMed ID: 25801086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain.
    Chu YC; Guan Y; Skinner J; Raja SN; Johns RA; Tao YX
    Pain; 2005 Dec; 119(1-3):113-123. PubMed ID: 16297560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors.
    Gómez-Vidal JA; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2004 Jan; 47(3):703-10. PubMed ID: 14736250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.